Page 40 - JCBP-2-1

Journal of Clinical and
Basic Psychosomatics The endocannabinoid system

Endocannabinoid and prostanoid crosstalk in pain. Trends https://doi.org/10.1146/annurev-neuro-062111-150420
Mol Med, 25: 882–896.
94. Vanini G, Torterolo P, 2021, Sleep-wake neurobiology. Adv
https://doi.org/10.1016/j.molmed.2019.04.009 Exp Med Biol, 1297: 65–82.
83. Diaz MM, Caylor J, Strigo I, et al., 2022, Toward composite https://doi.org/10.1007/978-3-030-61663-2_5
pain biomarkers of neuropathic pain-focus on peripheral 95. Wang Z, Wang Z, Lu T, et al., 2022, The microbiota-gut-
neuropathic pain. Front Pain Res (Lausanne), 3: 869215. brain axis in sleep disorders. Sleep Med Rev, 65: 101691.
https://doi.org/10.3389/fpain.2022.869215 https://doi.org/10.1016/j.smrv.2022.101691
84. Cohen SP, Fitzcharles MA, Hauser W, 2022, Nociplastic pain 96. Patke A, Young MW, Axelrod S, 2020, Molecular mechanisms
is functional pain-authors’ reply. Lancet, 399: 1604. and physiological importance of circadian rhythms. Nat Rev
https://doi.org/10.1016/s0140-6736(21)02506-x Mol Cell Biol, 21: 67–84.
85. Song LN, 1991, Stress-induced changes in glucocorticoid https://doi.org/10.1038/s41580-019-0179-2
receptors: Molecular mechanisms and clinical implications. 97. Crocq MA, 2020, History of cannabis and the
Mol Cell Endocrinol, 80: C171–C174. endocannabinoid system. Dialogues Clin Neurosci, 22:
https://doi.org/10.1016/0303-7207(91)90133-d 223–228.
86. Köbler P, Krauss-Köstler EK, Stein B, et al., 2022, Specialized https://doi.org/10.31887/dcns.2020.22.3/mcrocq
biopsychosocial care in inpatient somatic medicine units-a 98. Wu J, 2019, Cannabis, cannabinoid receptors, and
pilot study. Front Public Health, 10: 844874. endocannabinoid system: Yesterday, today, and tomorrow.
https://doi.org/10.3389/fpubh.2022.844874 Acta Pharmacol Sin, 40: 297–299.
87. Miranda A, Peek E, Ancoli‐Israel S, et al., 2023, The role https://doi.org/10.1038/s41401-019-0210-3
of cannabis and the endocannabinoid system in sleep 99. Rana T, Behl T, Sehgal A, et al., 2021, Integrating
regulation and cognition: A review of human and animal endocannabinoid signalling in depression. J Mol Neurosci,
studies. Behav Sleep Med, 3: 1–17. 71: 2022–2034.
https://doi.org/10.1080/15402002.2023.2232497 https://doi.org/10.1007/s12031-020-01774-7
88. Simon L, Admon R, 2023, From childhood adversity to 100. Sharafi A, Pakkhesal S, Fakhari A, et al., 2022, Rapid
latent stress vulnerability in adulthood: The mediating treatments for depression: Endocannabinoid system as a
roles of sleep disturbances and HPA axis dysfunction. therapeutic target. Neurosci Biobehav Rev, 137: 104635.
Neuropsychopharmacology, 48: 1425–1435.
https://doi.org/10.1016/j.neubiorev.2022.104635
https://doi.org/10.1038/s41386-023-01638-9
101. Behl T, Makkar R, Sehgal A, et al., 2022, Exploration of
89. Kinlein SA, Karatsoreos IN, 2020, The hypothalamic- multiverse activities of endocannabinoids in biological
pituitary-adrenal axis as a substrate for stress resilience: systems. Int J Mol Sci, 23: 5734.
Interactions with the circadian clock. Front Neuroendocrinol,
56: 100819. https://doi.org/10.3390/ijms23105734
102. Bright U, Akirav I, 2022, Modulation of endocannabinoid
https://doi.org/10.1016/j.yfrne.2019.100819
system components in depression: Pre-clinical and clinical
90. Kesner AJ, Lovinger DM, 2020, Cannabinoids, evidence. Int J Mol Sci, 23: 5526.
endocannabinoids and sleep. Front Mol Neurosci, 13: 125.
https://doi.org/10.3390/ijms23105526
https://doi.org/10.3389/fnmol.2020.00125
103. Gallego-Landin I, García-Baos A, Castro-Zavala A, et al.,
91. Murillo-Rodríguez E, Budde H, Veras AB, et al., 2020, The 2021, Reviewing the role of the endocannabinoid system
endocannabinoid system may modulate sleep disorders in in the pathophysiology of depression. Front Pharmacol,
aging. Curr Neuropharmacol, 18: 97–108. 12: 762738.
https://doi.org/10.2174/1570159x17666190801155922 https://doi.org/10.3389/fphar.2021.762738
92. Musella A, Centonze D, 2023, Electrophysiology of 104. Dong MX, Chen GH, Hu L, 2020, Dopaminergic system
endocannabinoid signaling. Methods Mol Biol, 2576: alteration in anxiety and compulsive disorders: A systematic
461–475. review of neuroimaging studies. Front Neurosci, 14: 608520.
https://doi.org/10.1007/978-1-0716-2728-0_38 https://doi.org/10.3389/fnins.2020.608520
93. Katona I, Freund TF, 2012, Multiple functions of 105. Forsythe ML, Boileau AJ, 2021, Use of cannabinoids for the
endocannabinoid signaling in the brain. Annu Rev Neurosci, treatment of patients with post-traumatic stress disorder.
35: 529–558. J Basic Clin Physiol Pharmacol, 33: 121–132.

Volume 2 Issue 1 (2024) 16 https://doi.org/10.36922/jcbp.2288